In the study, NF-κB, PI3K/AKT, and MAPKs (p38, ERK1/2 and JNK) pathways were all investigated for the first time fully revealing the underlying molecular mechanism by which juglanin prevented lung cancer progression. Here, MAPK8 is linked to lung carcinoma.